MARKET

CLLS

CLLS

Cellectis
NASDAQ
1.110
-0.010
-0.89%
Pre Market: 1.350 +0.24 +21.62% 08:34 11/11 EST
OPEN
1.118
PREV CLOSE
1.120
HIGH
1.170
LOW
1.101
VOLUME
32.49K
TURNOVER
0
52 WEEK HIGH
5.45
52 WEEK LOW
0.8808
MARKET CAP
80.69M
P/E (TTM)
-1.7077
1D
5D
1M
3M
1Y
5Y
1D
Cellectis to Report Third-Quarter 2026 Results on Nov. 12
TipRanks · 1d ago
Weekly Report: what happened at CLLS last week (1102-1106)?
Weekly Report · 2d ago
Weekly Report: what happened at CLLS last week (1026-1030)?
Weekly Report · 11/02 09:32
Cellectis S.A. Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with .HEAL-101 at ESGCT 2026
NASDAQ · 10/28 11:13
Cellectis Showcases Strong Preclinical Data for APOC3 Base Editor .HEAL-101 at ESGCT 2026
TipRanks · 10/28 10:38
Cellectis' .HEAL-101 Lowers Triglycerides In Preclinical Study; Phase 1 Data Expected In H2'27
NASDAQ · 10/28 10:33
Cellectis sees FY27 adjusted EPS $21.50
TipRanks · 10/26 20:50
Cellectis sees FY27 capital expenditures $1.5B-$2B
TipRanks · 10/26 20:50
More
About CLLS
Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development, and commercialization of rational genome engineering technologies. The Company develops immunotherapies that aim to force the immune system to target and eradicate cancer cells. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid (DNA) matrices into Meganuclease Recombination Systems (MRS), used for gene excision, correction or replacement. Cellectis SA markets its technologies mainly for use in the research field, in pharmaceutical drug discovery programs, in the agronomics, bioproduction, and biotherapeutics fields. Cellectis SA operates several subsidiaries. The Company operates in France and the United States, among others.

Webull offers Cellectis SA (ADR) stock information, including NASDAQ: CLLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLLS stock methods without spending real money on the virtual paper trading platform.